IDEAYA Biosciences, Inc. Financial Ratios — IDYA Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-60.25	-40.06	-16.77	-14.64	-15.25	-21.78	-30.95	-10.18
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	-173.83	-169.06	-115.82	-557.71	-4,616.3	-70.74
Operating Margin (%)	- -	- -	- -	-180.9	-179.91	-122.72	-574.85	-4,671.07	-72.84
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-176.55	-178.1	-115.17	-483.05	-3,921.1	-51.99
Profit Margin (%)	- -	- -	- -	-176.55	-178.1	-115.17	-483.05	-3,921.1	-51.99
Net Income to Common Margin (%)	- -	- -	- -	-176.55	-178.1	-115.17	-483.05	-3,921.1	-51.99
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	7	7	5	3	3	19	28
ST Debt	- -	- -	1	2	2	2	2	- -	- -
LT Debt	- -	- -	6	5	3	2	1	19	28
Total Debt/EBITDA	- -	- -	-0.16	-0.2	-0.11	-0.06	-0.02	-0.06	-0.18
Net Debt/EBITDA	0.42	0.58	0.79	2.12	1.95	1.16	1.2	0.26	0.73
Total Debt/EBIT	- -	- -	-0.15	-0.19	-0.1	-0.06	-0.02	-0.06	-0.18
Net Debt/EBIT	0.41	0.56	0.77	2.04	1.83	1.1	1.17	0.26	0.71
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-92.51	-52.33	-81.85	-42.57	-46.35	-60.67	-53.65	-55.41	-66.39
Long-Term Debt/Equity (%)	- -	- -	5.6	2.61	1.15	0.46	0.18	1.78	2.7
Long-Term Debt/Capital (%)	- -	- -	-6.56	-4.31	-2.03	-0.69	-0.33	-3.13	-3.89
Long-Term Debt/Total Assets (%)	- -	- -	4.98	1.74	0.91	0.42	0.17	1.68	2.49
Total Debt/Equity (%)	- -	- -	6.75	3.39	1.72	1	0.46	1.81	2.73
Total Debt/Capital (%)	- -	- -	-7.9	-5.59	-3.02	-1.5	-0.83	-3.18	-3.94
Total Debt/Total Assets (%)	- -	- -	5.99	2.25	1.36	0.9	0.44	1.71	2.52
Net Debt to Equity	37.87	41.89	-33.93	-36.33	-30.53	-19.64	-25.28	-7.97	-11.03
Net Debt/Capital (%)	26.94	28.87	28.44	37.46	34.92	22.84	31.25	12.26	13.74
EBITDA	-14	-36	-43	-34	-47	-59	-130	-323	-155
EBITDA-CapEx	-16	-37	-44	-34	-50	-62	-133	-327	-157
Operating Income (Loss)	-14	-36	-44	-35	-50	-63	-134	-327	-159

Liquidity (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	5.41	16.62	14.26	7.34	5.46	11.5	19.38	14.68	10.87
Current Ratio	5.58	16.75	14.65	7.47	5.56	11.68	19.65	14.97	11.34
Quick Ratio	5.41	16.62	14.26	7.39	5.49	11.51	19.38	14.68	10.97
CFO/Avg Current Liab	- -	-7.04	-6.36	2.43	-1.33	-2.27	-3.92	-6.77	-1.36
Common Equity/Total Assets	-92.51	-52.33	-81.85	-42.57	-46.35	-60.67	-53.65	-55.41	-66.39
Long-Term Debt/Equity (%)	- -	- -	5.6	2.61	1.15	0.46	0.18	1.78	2.7
Long-Term Debt/Capital (%)	- -	- -	-6.56	-4.31	-2.03	-0.69	-0.33	-3.13	-3.89
Long-Term Debt/Total Assets (%)	- -	- -	4.98	1.74	0.91	0.42	0.17	1.68	2.49
Total Debt/Equity (%)	- -	- -	6.75	3.39	1.72	1	0.46	1.81	2.73
Total Debt/Capital (%)	- -	- -	-7.9	-5.59	-3.02	-1.5	-0.83	-3.18	-3.94
Total Debt/Total Assets (%)	- -	- -	5.99	2.25	1.36	0.9	0.44	1.71	2.52
CFO/Total Liabilities	-36.8	-18.98	-311.98	55.47	-69.87	-226.35	-408.22	-381.23	-82.3
CFO/CapEx	-6.96	-16.17	-29.06	112.5	-21.1	-25.32	-48.66	-64.19	-30.02
Altman's Z-Score	-3.26	-0.92	3.03	2.16	5.9	11.53	43.04	18.35	20.7

Working Capital (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	20.82	18.75	77.52	204.24	666.67	145,806.67
Days Sales Outstanding	- -	- -	- -	17.53	19.46	4.71	1.79	0.55	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	94	346	833	753	2,047	2,099	3,059
- Cash & Cash Equivalents	6	21	34	72	92	69	157	84	113
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	7	7	5	3	3	19	28
Enterprise Value	-13	-90	2	69	592	392	1,524	1,442	2,447
Total Capital	-16	-51	-86	-120	-172	-232	-345	-604	-709
Total Debt/Capital (%)	- -	- -	-7.9	-5.59	-3.02	-1.5	-0.83	-3.18	-3.94
Total Debt / EV	- -	- -	4.39	0.1	0.01	0.01	- -	0.01	0.01
EV/Sales	- -	- -	- -	3.54	21.18	7.69	65.18	206	11.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	1.25	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	1.24	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	94	346	833	753	2,047	2,099	3,059
Diluted Enterprise Value	-6	-21	66	281	747	688	1,892	2,034	2,974
EV per Share	- -	- -	0.12	2.8	16.79	9.45	26.5	17.65	27.66
TTM Sales	- -	- -	- -	20	28	51	23	7	219
TTM EBITDA	-14	-36	-43	-34	-47	-59	-130	-323	-155
TTM Operating Income	-14	-36	-44	-35	-50	-63	-134	-327	-159
TTM Cash Flow to Firm	-12	-28	-39	55	-56	-87	-115	-248	-71
TTM Free Cash Flow to Firm	-10	-26	-38	56	-53	-84	-113	-244	-69

Multiples (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-2.47	6.19	-15.68	-8.99	-18.13	-8.61	-44.51
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-13	-90	2	69	592	392	1,524	1,442	2,447
Low Price	- -	- -	4.89	2.95	13.16	8.14	13.29	24.2	13.45
EV/Sales	- -	- -	- -	3.54	21.18	7.69	65.18	206	11.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-2.37	-7.35	-15.33	-9.84	-11.78	-11.05	-18.85
Price/Earnings High	- -	- -	-5.03	-14.31	-19.84	-17.02	-18.59	-14.21	-28.86
Price/Earnings Low	- -	- -	-1.46	-2.11	-9.32	-5.75	-6.77	-7.2	-10.47
Price/Book Value	- -	- -	-1.01	-2.73	-4.72	-3.2	-5.87	-3.37	-4.15
Price/Book Value Average	- -	- -	-1.08	-2	-4.32	-2.45	-3.82	-4.87	-2.91
Price/Book Value High	- -	- -	-2.28	-3.89	-5.58	-4.24	-6.03	-6.26	-4.45
Price/Book Value Low	- -	- -	-0.66	-0.57	-2.62	-1.43	-2.19	-3.17	-1.62
Price/Tangible Book Value	- -	- -	0.93	1.75	2.76	2.15	3.3	1.98	2.99
Price/Tangible Book Value Average	- -	- -	0.99	1.28	2.53	1.65	2.14	2.86	2.1
Price/Tangible Book Value High	- -	- -	2.1	2.49	3.27	2.86	3.38	3.68	3.21
Price/Tangible Book Value Low	- -	- -	0.61	0.37	1.54	0.97	1.23	1.87	1.16
Price/Sales	- -	- -	- -	17.71	29.83	14.79	87.52	299.88	13.99
Price/Sales Average	- -	- -	- -	12.98	27.3	11.33	56.92	433.24	9.8
Price/Sales High	- -	- -	- -	25.27	35.33	19.6	89.8	557.04	15
Price/Sales Low	- -	- -	- -	3.73	16.6	6.62	32.69	282.37	5.44
Price/Cash Flow	- -	- -	-2.38	6.24	-14.94	-8.64	-17.76	-8.48	-43.02
Price/Cash Flow Average	- -	- -	-2.53	4.57	-13.68	-6.62	-11.55	-12.25	-30.15
Price/Cash Flow High	- -	- -	-5.37	8.9	-17.7	-11.45	-18.23	-15.75	-46.15
Price/Cash Flow Low	- -	- -	-1.55	1.31	-8.32	-3.87	-6.63	-7.98	-16.74
Price/Free Cash Flow Average	- -	- -	-2.62	4.53	-14.36	-6.89	-11.8	-12.44	-31.19
Price/Free Cash Flow High	- -	- -	-5.56	8.82	-18.58	-11.92	-18.61	-16	-47.74
Price/Free Cash Flow Low	- -	- -	-1.61	1.3	-8.73	-4.03	-6.77	-8.11	-17.32
EV/Sales Average	- -	- -	- -	9.64	24.19	10.05	50.33	423.92	9.41
EV/Sales High	- -	- -	- -	21.93	32.22	18.32	83.21	547.73	14.61
EV/Sales Low	- -	- -	- -	0.39	13.49	5.34	26.1	273.06	5.05
EV/EBITDA Average	0.42	0.58	-1.68	-5.54	-14.31	-8.68	-9.02	-9.18	-13.31
EV/EBITDA High	0.42	0.58	-4.27	-12.61	-19.06	-15.82	-14.92	-11.87	-20.66
EV/EBITDA Low	0.42	0.58	-0.79	-0.22	-7.98	-4.61	-4.68	-5.92	-7.14
EV/EBIT Average	0.41	0.56	-1.63	-5.33	-13.45	-8.19	-8.76	-9.08	-12.92
EV/EBIT High	0.41	0.56	-4.15	-12.12	-17.91	-14.93	-14.48	-11.73	-20.06
EV/EBIT Low	0.41	0.56	-0.76	-0.22	-7.5	-4.36	-4.54	-5.85	-6.94
Last Price	- -	- -	7.5	14	23.64	18.17	35.58	25.7	34.57
High Price	- -	- -	16.9	19.97	28	24.09	36.51	47.74	37.08
Enterprise Value Average	-6	-21	72	188	676	512	1,177	2,967	2,059
Enterprise Value High	-6	-21	184	428	900	933	1,946	3,834	3,196
Enterprise Value Low	-6	-21	34	8	377	272	610	1,911	1,105

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	19	19	20	30	39	48	65	87	88
Diluted Weighted Avg Shares	14	14	12	25	35	41	58	82	88
Basic Weighted Avg Shares	14	14	12	25	35	41	58	82	88
Revenue per Share	- -	- -	- -	0.79	0.79	1.23	0.41	0.09	2.47
EBITDA per Share	-0.99	-2.49	-3.44	-1.37	-1.34	-1.42	-2.27	-3.96	-1.75
Operating Income per Share	-1.01	-2.56	-3.54	-1.43	-1.43	-1.51	-2.34	-4	-1.8
Basic EPS, GAAP	-0.83	-2.41	-3.36	-1.4	-1.41	-1.42	-1.96	-3.36	-1.28
Basic EPS from Cont Ops	-0.83	-2.41	-3.36	-1.4	-1.41	-1.42	-1.96	-3.36	-1.28
Diluted EPS, GAAP	-0.83	-2.41	-3.36	-1.4	-1.41	-1.42	-1.96	-3.36	-1.28
Diluted EPS from Cont Ops	-0.83	-2.41	-3.36	-1.4	-1.41	-1.42	-1.96	-3.36	-1.28
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.86	-1.94	-3.15	2.24	-1.58	-2.1	-2	-3.03	-0.8
Free Cash Flow per Basic Share	-0.98	-2.06	-3.25	2.22	-1.66	-2.19	-2.04	-3.08	-0.83
Cash & Equivalents per Share	0.92	6.32	7.92	11.47	7	8.8	9.13	8.28	7.23
Book Value per Share	-1.14	-3.55	-7.4	-5.14	-5.01	-5.68	-6.06	-7.63	-8.32
Tangible Book Value per Share	-1.11	-3.44	8.03	8.02	8.55	8.43	10.8	12.97	11.56

IDEAYA Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)